Il Dong Pharmaceutical Co Ltd Cash Flow Quality Index

Latest as of September 2025: 0.50x

Il Dong Pharmaceutical Co Ltd cash flow quality index. Il Dong Pharmaceutical Co Ltd (249420) has a Cash Flow Quality Index of 0.50x as of September 2025. Operating cash flow of ₩11.28 Billion is below net income of ₩22.41 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow to debt ratio of Il Dong Pharmaceutical Co Ltd to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

0.50x
Operating CF / Net Income

Operating Cash Flow

₩11.28 Billion
KRW

Net Income

₩22.41 Billion
KRW

Data as of

Sep 2025
Most recent filing

Cash Flow Quality Index of Il Dong Pharmaceutical Co Ltd (2016–2018)

Cash flow quality index of Il Dong Pharmaceutical Co Ltd from 2016 to 2018. Historical Cash Flow Quality Index for Il Dong Pharmaceutical Co Ltd across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. See Il Dong Pharmaceutical Co Ltd (249420) balance sheet quality index to measure how much of total assets are equity-financed.

Il Dong Pharmaceutical Co Ltd Cash Flow Quality Index by Year (2016–2018)

Il Dong Pharmaceutical Co Ltd cash flow quality index by year from 2016 to 2018. Year-by-year earnings quality comparison for Il Dong Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see how efficiently does Il Dong Pharmaceutical Co Ltd generate cash.

Year Quality Index Operating CF (KRW) Net Income YoY Change
2018 5.24x ₩66.65 Billion ₩12.72 Billion ▲ +41.0%
2017 3.72x ₩73.72 Billion ₩19.84 Billion ▲ +1.7%
2016 3.66x ₩45.98 Billion ₩12.58 Billion —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.